Computational precision medicine company
Genialis has raised €12M across 1 funding round from 6 investors, most recently a Series A round in Mar 2023. Based in Ljubljana, Slovenia; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-03-29 | Series A | €12M |
| Debiopharm Innovatoin Fund,First Star Ventures,P5 Health Ventures,Pikas,Redalpine Venture Partners,Taiwania Capital |
| View deal → |
